- Home
- AKRO vs IAG Comparison
AKRO vs IAG Comparison
Compare AKRO & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- IAG
- Stock Information
- Founded
- AKRO 2017
- IAG 1990
- Country
- AKRO United States
- IAG Canada
- Employees
- AKRO N/A
- IAG N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- IAG Precious Metals
- Sector
- AKRO Health Care
- IAG Basic Materials
- Exchange
- AKRO Nasdaq
- IAG Nasdaq
- Market Cap
- AKRO 3.9B
- IAG 4.0B
- IPO Year
- AKRO 2019
- IAG 1996
- Fundamental
- Price
- AKRO $50.56
- IAG $7.03
- Analyst Decision
- AKRO Strong Buy
- IAG Buy
- Analyst Count
- AKRO 6
- IAG 6
- Target Price
- AKRO $82.50
- IAG $8.61
- AVG Volume (30 Days)
- AKRO 1.1M
- IAG 13.2M
- Earning Date
- AKRO 08-08-2025
- IAG 08-07-2025
- Dividend Yield
- AKRO N/A
- IAG N/A
- EPS Growth
- AKRO N/A
- IAG 405.77
- EPS
- AKRO N/A
- IAG 1.42
- Revenue
- AKRO N/A
- IAG $1,771,200,000.00
- Revenue This Year
- AKRO N/A
- IAG $49.23
- Revenue Next Year
- AKRO N/A
- IAG $8.82
- P/E Ratio
- AKRO N/A
- IAG $4.95
- Revenue Growth
- AKRO N/A
- IAG 61.05
- 52 Week Low
- AKRO $21.34
- IAG $3.44
- 52 Week High
- AKRO $58.40
- IAG $8.38
- Technical
- Relative Strength Index (RSI)
- AKRO 44.48
- IAG 46.68
- Support Level
- AKRO $50.60
- IAG $6.90
- Resistance Level
- AKRO $52.55
- IAG $7.22
- Average True Range (ATR)
- AKRO 1.83
- IAG 0.26
- MACD
- AKRO -0.35
- IAG -0.00
- Stochastic Oscillator
- AKRO 17.66
- IAG 33.56
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.